Fm. Abuzidan et al., ROLE OF PLATELET-ACTIVATING-FACTOR ANTAGONISM IN POSTHEMORRHAGE SEPTIC SHOCK IN PIGS, The journal of trauma, injury, infection, and critical care, 41(4), 1996, pp. 634-640
Objectives: To study the role of platelet-activating factor (PAF) anta
gonism in posthemorrhage septic shock in pigs. Design: Experimental st
udy. Materials and Methods: Twelve anesthetized pigs were bled, kept w
ith a mean arterial pressure of 30 mm Hg for 30 minutes, and then resu
scitated with 50 mL/kg of isotonic saline. A continuous infusion of Es
cherichia coli endotoxin 36 mu g/kg/hour was give intravenously for 3.
5 hours starting 30 minutes after resuscitation. The animals were divi
ded into two groups of six each. One group received 1 mg/kg of BB-882
(a potent specific PAF receptor antagonist) as a bolus during resuscit
ation, followed by a continuous infusion of BB-882 1 mg/kg/hour. The o
ther group received vehicle alone. Measurements and Main Results: The
measured variables were blood temperature, heart rate, intravascular p
ressures, cardiac output, systemic and pulmonary vascular resistance,
lung-thorax compliance, blood gases, hemoglobin oxygen saturation, pac
ked cell volume, and blood sugar and serum lactic acid concentrations.
The group treated with BB-882 had significantly higher intracardiac p
ressures and cardiac output, and had less increase in systemic vascula
r resistance. The BB-882 group had significantly less lactic acidemia
than the control group (p < 0.05, analysis of variance appropriate for
repeated measurement design). BB-882 had no effect on endotoxin-induc
ed hypoxia or reduced lung-thorax compliance. Conclusions: PAF antagon
ism reduced the increase in systemic vascular resistance, improved car
diac output, and reduced lactic acidemia in posthemorrhage septic shoc
k in pigs, but it did not improve hypoxia or reduced lung-thorax compl
iance.